Briggs A - Search Results

1

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting.

Bouwmeester W, Briggs A, van Hout B, Hájek R, Gonzalez-McQuire S, Campioni M, DeCosta L, Brozova L. Bouwmeester W, et al. Among authors: briggs a. Oncol Ther. 2019 Dec;7(2):141-157. doi: 10.1007/s40487-019-00100-5. Epub 2019 Nov 3. Oncol Ther. 2019. PMID: 32699987 Free PMC article.

2

Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review.

Hájek R, Gonzalez-McQuire S, Szabo Z, Delforge M, DeCosta L, Raab MS, Bouwmeester W, Campioni M, Briggs A. Hájek R, et al. Among authors: briggs a. BMJ Open. 2020 Jul 14;10(7):e034209. doi: 10.1136/bmjopen-2019-034209. BMJ Open. 2020. PMID: 32665382 Free PMC article.

3

Modelling Comparative Efficacy of Drugs with Different Survival Profiles: Ipilimumab, Vemurafenib and Dacarbazine in Advanced Melanoma.

Lee D, Porter J, Hertel N, Hatswell AJ, Briggs A. Lee D, et al. Among authors: briggs a. BioDrugs. 2016 Aug;30(4):307-19. doi: 10.1007/s40259-016-0178-1. BioDrugs. 2016. PMID: 27177756

4

A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia.

Städler N, Shang A, Bosch F, Briggs A, Goede V, Berthier A, Renaudin C, Leblond V. Städler N, et al. Among authors: briggs a. Adv Ther. 2016 Oct;33(10):1814-1830. doi: 10.1007/s12325-016-0398-2. Epub 2016 Aug 17. Adv Ther. 2016. PMID: 27535291 Free PMC article. Review.

5

Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.

Briggs A, Paracha N, Rosettie K, Upton A, Bokemeyer C, Lassen U, Sullivan SD. Briggs A, et al. Oncology. 2022;100(2):124-130. doi: 10.1159/000519767. Epub 2021 Nov 29. Oncology. 2022. PMID: 34844255 Free PMC article.

6

Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease.

Briggs A, Spencer M, Wang H, Mannino D, Sin DD. Briggs A, et al. Arch Intern Med. 2008 Jan 14;168(1):71-9. doi: 10.1001/archinternmed.2007.37. Arch Intern Med. 2008. PMID: 18195198

7

Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up.

Chaudhary MA, Edmondson-Jones M, Baio G, Mackay E, Penrod JR, Sharpe DJ, Yates G, Rafiq S, Johannesen K, Siddiqui MK, Vanderpuye-Orgle J, Briggs A. Chaudhary MA, et al. Among authors: briggs a. Med Decis Making. 2023 Jan;43(1):91-109. doi: 10.1177/0272989X221132257. Epub 2022 Oct 19. Med Decis Making. 2023. PMID: 36259353

8

How Do Diabetes Models Measure Up? A Review of Diabetes Economic Models and ADA Guidelines.

Govan L, Wu O, Lindsay R, Briggs A. Govan L, et al. Among authors: briggs a. J Health Econ Outcomes Res. 2015 Dec 16;3(2):132-152. doi: 10.36469/9831. eCollection 2016. J Health Econ Outcomes Res. 2015. PMID: 37663318 Free PMC article.

9

Prognosis Research Strategy (PROGRESS) 3: prognostic model research.

Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG; PROGRESS Group. Steyerberg EW, et al. PLoS Med. 2013;10(2):e1001381. doi: 10.1371/journal.pmed.1001381. Epub 2013 Feb 5. PLoS Med. 2013. PMID: 23393430 Free PMC article. Review.

10

Rational allocation of resources available for healthcare: understanding cost effectiveness analyst.

Briggs A. Briggs A. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19492. doi: 10.7448/IAS.17.4.19492. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394001 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

969 results

Search Page